Medical Aesthetics Market Overview

According to recent market research conducted by the CMI team, the global Medical Aesthetics Market is poised for substantial growth, with expectations of recording a compound annual growth rate (CAGR) of 8.4% between 2024 and 2033. In the year 2024, the market size is projected to attain a valuation of USD 17,501.3 million. By the year 2033, the valuation is anticipated to rise significantly, reaching approximately USD 36,168.8 million.

Medical Aesthetics Market: Growth Factors and Dynamics

Increasing demand for aesthetic procedures: There has been a notable surge in global demand for aesthetic treatments, fueled by growing public awareness, continuous advancements in medical technologies, and evolving societal norms that embrace personal appearance enhancement. This shift has contributed to a broader acceptance and higher frequency of aesthetic procedures.

Aging population: The growing demographic of aging individuals, particularly in economically advanced regions, is accelerating the need for anti-aging solutions. This age group increasingly seeks procedures aimed at preserving a youthful look, thereby boosting the demand for various medical aesthetic services and treatments.

Advancements in technology: Ongoing technological progress in the development of energy-based devices, injectables, and other aesthetic tools has led to the emergence of safer and more effective treatment options. These innovations often come with the benefit of minimal recovery time, which has made aesthetic treatments more attractive and accessible to a larger consumer base.

Rising disposable income: In emerging economies, rising levels of disposable income combined with an increasing focus on self-care and appearance enhancement have expanded the demographic seeking aesthetic interventions. This broader participation across income brackets is contributing to the growth of the overall market.

Shift towards minimally invasive procedures: The market is witnessing a notable shift from traditional surgical treatments to minimally invasive alternatives. These procedures are gaining popularity due to their reduced risk factors, shorter downtime, and minimal complications. As a result, there has been a steady rise in demand for non-surgical aesthetic treatments.

Expanding market reach: Market players are employing various strategies to broaden the accessibility and visibility of medical aesthetics. These include geographic expansion into untapped regions, establishing partnerships with cosmetic surgery centers and dermatology clinics, and leveraging digital platforms for outreach. Such initiatives have significantly increased the market penetration of aesthetic services globally.

Medical Aesthetics Market: Partnerships and Acquisitions

In 2022, Apyx Medical obtained FDA clearance for its Renuvion device, specifically approved for use in aesthetic procedures addressing skin laxity in the neck area. This regulatory milestone expanded the device’s applicable treatment areas, providing patients with new and advanced options for cosmetic enhancement.

In the same year, Allergan, a subsidiary of AbbVie Inc., received FDA approval for JUVÉDERM VOLBELLA XC, a product developed to improve the appearance of infraorbital hollows in adults aged 21 and older. This approval enhanced Allergan’s aesthetics product portfolio, reinforcing its competitive standing within the U.S. market.

Medical Aesthetics Market: COVID-19 Impact Analysis

The COVID-19 pandemic significantly influenced the medical aesthetics industry, presenting both opportunities and challenges across various operational aspects. Key impacts are highlighted below:

Disruption of services: The onset of the pandemic saw the temporary closure or limited operation of many medical aesthetics clinics due to government-imposed lockdowns and health regulations. This resulted in a considerable reduction in patient volume for elective procedures.

Economic uncertainty: The financial strain experienced by many individuals during the pandemic, including job losses and reduced income, led to a decline in discretionary spending. Consequently, many consumers deferred or canceled aesthetic treatments due to financial insecurity.

Pent-up demand release: With the easing of restrictions and progress in vaccination efforts, the industry has witnessed a rebound effect, with patients rescheduling or initiating aesthetic treatments they had postponed during the pandemic, thereby contributing to market recovery.

Focus on safety and hygiene: To restore consumer confidence, aesthetics providers have adopted stringent hygiene and safety protocols to protect both staff and clients. This renewed focus on cleanliness and patient well-being has become a critical part of service delivery.

Innovation in digital consultations: The industry experienced a rapid shift toward telehealth services, particularly virtual consultations, during the pandemic. This mode of engagement remains popular post-pandemic, providing a convenient and accessible avenue for patients to receive expert advice and personalized treatment plans remotely.

Flexible payment options: In response to economic challenges, many service providers have introduced flexible payment schemes and financing alternatives. These measures have helped reduce the financial burden on clients, making aesthetic treatments more accessible and budget-friendly for a wider audience.

List of the prominent players in the Medical Aesthetics Market

Allergan Aesthetics (AbbVie Inc.)
Galderma S.A.
Merz Pharmaceuticals GmbH
Bausch Health Companies Inc.
Syneron Candela
Alma Lasers (Sisram Medical Ltd.)
Cynosure LLC (Hologic Inc.)
Lumenis Ltd.
Solta Medical (Valeant Pharmaceuticals International Inc.)
Cutera Inc.
Zimmer MedizinSysteme GmbH
Sciton Inc.
Sinclair Pharma plc
Sientra Inc.
Fotona d.o.o.

https://www.custommarketinsights.com/report/medical-aesthetics-market/